Can artificial intelligence improve the accuracy of routine colonoscopy screenings for colorectal cancer?

Health · Published 3 October 2026 Swipe more like this →

In short: Colonoscopy is a standard procedure for detecting colorectal cancer, but its effectiveness varies. Recent research suggests that while AI-assisted tools may help identify tiny polyps, their impact on detecting larger, more significant lesions remains minimal. Understanding these limitations is essential for evaluating how technology might shape the future of cancer screening.

A colonoscopy involves using a flexible tube equipped with a camera to examine the entire 120 to 150 cm length of the large bowel. This procedure allows clinicians to inspect the colon lining for ulcers or precancerous growths, which can be removed during the exam to prevent cancer development. While widely used in the United States for adults aged 45 to 75, the procedure is not without limitations; it is notably more effective at reducing cancer deaths associated with the left side of the colon than the right.

Recent systematic reviews have scrutinized the role of artificial intelligence in enhancing these screenings. Analysis of 13 randomized controlled trials indicates that AI systems offer only a modest advantage in spotting diminutive polyps, defined as those 5 mm or smaller. For larger growths, the evidence shows minimal benefit, and current findings are classified as having very low to low certainty. Because polyps typically require a decade or more to evolve into malignant tumors, the standard recommendation for those with normal results is a ten-year interval before the next screening.

Beyond technical accuracy, structural barriers influence screening outcomes. A national geospatial analysis of the United States found that simply increasing the number of providers in a region does not necessarily lead to higher screening rates. Factors such as socioeconomic status and referral pathways appear to play a larger role in patient participation than geographic proximity. As ongoing large-scale trials like the CONFIRM study continue to evaluate different screening methods, the medical community remains focused on balancing technological innovation with the practical realities of patient access and long-term diagnostic efficacy.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• The silent progression of colorectal cancer from polyps to malignancy
• The decade-long transition from a harmless polyp to colon cancer
• Why your bowel movements might hold the key to life-saving medical breakthroughs
• Better scans can make cancer survival statistics improve without anyone living longer
• The rapid evolution of cancer research from genomics to AI
• Half of colorectal cancers hide until screening finds them
• Why your brain sometimes lies to you and how to catch it in action
• Why the first few days of breast milk are called liquid gold
• Modern talking therapy traces its roots to Stoic philosophers and Pavlov's dogs
• Forty percent of comas begin with drug poisoning
• Many people with coeliac disease feel fine until gluten leaves their diet
• The wartime committee that ran revolutionary France and then devoured its own

More in Health, medicine and disease · More in Health · Latest · A–Z · All topics